Armata Pharmaceuticals, Inc. - Director's Dealing 2005

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: TARGETED GENETICS CORP /WA/ (TGEN)
CIK: 0000921114
Period of Report: 2005-08-02

Reporting Person: BIOGEN IDEC INC (10% Owner)
Reporting Person: BIOGEN IDEC MA INC (10% Owner)

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2005-08-02	Common Stock, $0.01 Par Value	S	6900	$0.77	Disposed	11825548	Indirect
2005-08-02	Common Stock, $0.01 Par Value	S	1000	$0.7702	Disposed	11824548	Indirect
2005-08-02	Common Stock, $0.01 Par Value	S	2400	$0.771	Disposed	11822148	Indirect
2005-08-02	Common Stock, $0.01 Par Value	S	3000	$0.773	Disposed	11819148	Indirect
2005-08-02	Common Stock, $0.01 Par Value	S	1100	$0.78	Disposed	11818048	Indirect
2005-08-02	Common Stock, $0.01 Par Value	S	2800	$0.79	Disposed	11815248	Indirect
2005-08-03	Common Stock, $0.01 Par Value	S	4300	$0.76	Disposed	11810948	Indirect
2005-08-03	Common Stock, $0.01 Par Value	S	4600	$0.77	Disposed	11806348	Indirect
2005-08-03	Common Stock, $0.01 Par Value	S	100	$0.78	Disposed	11806248	Indirect

F1: Shares are owned indirectly by Biogen Idec Inc. and directly by its wholly-owned subsidiary Biogen Idec MA Inc., fka Biogen, Inc.